EGFR and non-small cell lung carcinoma: Our previous study has revealed that pulmonary lymphoepithelioma-like carcinoma had a better prognosis compared with other types of non-small-cell lung cancer and was sensitive to radiotherapy and chemotherapy but not to targeted EGFR-TKI therapy [9].